If you experience chest pain, dizziness, or nausea during sex, seek immediate medical help.

What Is So Special About Cenforce?

GREENSTONE is one of the longest running distributors of Authorized Generics in the U.S. across a broad range of therapeutic areas. GREENSTONE is committed to quality, value and excellence in everything we do, and dedicated to the goal of helping patients live healthier lives. GREENSTONE Authorized Generics are manufactured to the same standards and at the same facilities as Pfizer brand-name drugs. Patients can visit GreenstoneGenerics.com or call the GREENSTONE Pharmacy Locator Service at 1-855-222-8588 to find Authorized Generics at their nearest pharmacy. Sildenafil citrate can cause serious side effects. If it is not treated right away, priapism can permanently damage your penis sudden vision loss in one or both eyes. Stop taking Sildenafil citrate and call your healthcare provider right away if you have any sudden vision loss Some people may also have ringing in their ears (tinnitus) or dizziness.

Understanding Sildenafil

We’re patients, just like you, building technology to make healthcare accessible, affordable, and maybe even enjoyable. Today, we enable you to connect with a doctor and get treatment when and where you need it. Tomorrow, we aspire to be your first call for all your healthcare needs. Ro’s nationwide physician and pharmacy networks power three digital health clinics — Roman, Rory and Zero — providing a personalized end to end telehealth experience from diagnosis to delivery. GREENSTONE is part of the Upjohn business and a wholly owned subsidiary of Pfizer Inc., offering a leading portfolio of Authorized Generics. If you have these symptoms, stop taking sildenafil citrate and contact a doctor right away Before you take sildenafil citrate, tell your healthcare provider if you: have or have had heart problems such as a heart attack, irregular heartbeat, angina, chest pain, narrowing of the aortic valve, or heart failure have had heart surgery within the last 6 months have low blood pressure, or high blood pressure that is not controlled have had an erection that lasted for more than 4 hours have problems with your blood cells such as sickle cell anemia, multiple myeloma, or leukemia have retinitis pigmentosa, a rare genetic (runs in families) eye disease have ever had severe vision loss, including an eye problem called NAION have kidney problems or having kidney dialysis Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Sildenafil citrate may affect the way other medicines work, and other medicines may affect the way sildenafil citrate works, causing side effects. Especially tell your healthcare provider if you take any of the following: medicines called guanylate cyclase stimulators such as Adempas (riociguat) medicines called alpha-blockers, such as Hytrin (terazosin HCl), Flomax (tamsulosin HCl), Cardura (doxazosin mesylate), Minipress (prazosin HCl), Uroxatral (alfuzosin HCl), Jalyn (dutasteride and tamsulosin HCl), or Rapaflo (silodosin). In some patients, the use of with alpha-blockers can lead to a drop in blood pressure or to fainting medicines called HIV protease inhibitors, such as ritonavir (Norvir), indinavir sulfate (Crixivan), saquinavir (Fortovase or Invirase), or atazanavir sulfate (Reyataz) some types of oral antifungal medicines, such as ketoconazole (Nizoral) and itraconazole (Sporanox) some types of antibiotics, such as clarithromycin (Biaxin), telithromycin (Ketek), or erythromycin other medicines that treat high blood pressure Sildenafil citrate is the same medicine found in another drug called REVATIO. Sildenafil citrate should not be used with REVATIO or with other PAH treatments containing sildenafil or any other PDE5 inhibitors (such as Adcirca [tadalafil]) Sildenafil citrate does not protect against sexually transmitted diseases, including HIV. The most common side effects of sildenafil citrate: headache; flushing; upset stomach; abnormal vision, such as changes in color vision (such as having a blue color tinge) and blurred vision; stuffy or runny nose; back pain; muscle pain; nausea; dizziness; rash.

When One PDE5 Inhibitor Doesn’t Work: Can Another Help?

We routinely post information that may be important to investors on our website at In addition, to learn more, please visit us on and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer. Sildenafil citrate is a prescription medicine used to treat erectile dysfunction(ED). Do not take sildenafil citrate if you: take any medicines called nitrates, often prescribed for chest pain, or guanylate cyclase stimulators like Adempas (riociguat) for pulmonary hypertension. Your blood pressure could drop to an unsafe level are allergic to sildenafil, as contained in VIAGRA and REVATIO, or any of the ingredients in sildenafil citrate. Discuss your health with your doctor to ensure that you are healthy enough for sex. PFIZER DISCLOSURE NOTICE: The information contained in this release is as of January 23, 2020. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.

Viagra Note

ED affects about 30 million men in the U.S. ED is a medical condition often caused by an underlying condition such as heart disease, diabetes or depression. However, studies show men are 24% less likely than women to go to a doctor over a one-year period and that only 25% of men who experience ED get treated. The sildenafil citrate authorized generic is equivalent to the VIAGRA brand. See the Full Prescribing Information for Greenstone’s sildenafil citrate tablets at Ro is a patient-driven healthcare company that puts you in control of your health. This release contains forward-looking information about Greenstone’s exclusive supply agreement with Roman, a division of Ro, to offer Roman members access to the FDA-approved authorized generic version of Viagra (sildenafil citrate) and Greenstone’s Sildenafil Citrate authorized generic, including their potential benefits, that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

FREE SHIPPING ON ALL ORDERS OVER $199

For more information about Greenstone LLC and its products, visit Pfizer Inc.: Breakthroughs That Change Patients’ Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. Risks and uncertainties include, among other things, uncertainties regarding the potential benefits of the supply agreement; whether the Sildenafil Citrate authorized generic will be commercially successful; decisions by regulatory authorities impacting labeling, manufacturing processes, safety and/or other matters that could affect the availability or commercial potential of Sildenafil Citrate; other business effects, including the effects of industry, market, economic, political or regulatory conditions; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results,” as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at and Pfizer Media Steve Danehy (212) 733-1538[email protected] Investor: Ryan Crowe 212-733-8160[email protected] Ro Media Meghan Pianta 203-556-5970[email protected] (BUSINESS WIRE)--Pfizer announced today that it has withdrawn its application to switch the legal status of the 50 mg tablet strength of Viagra from ‘prescription only’ to ‘non-prescription’ in the European Union (EU). Viagra is a well established oral medication for the treatment of erectile dysfunction (ED) and all current doses of Viagra will continue to be available to patients by prescription from their doctor. Pfizer believes that Viagra 50 mg is a suitable candidate for non-prescription supply through pharmacists in the EU and meets the criteria set out by the European Commission guideline for changing the classification of a medicinal product to non-prescription. However, in a letter to the European Medicines Agency (EMEA), Pfizer said that it has decided to withdraw the application in order to fully consider comments from the EMEA’s Committee for Medicinal Products for Human Use (CHMP), recognizing that there were some concerns regarding the proposed supply of Viagra 50 mg tablets without a prescription in the EU. The CHMP noted that when Viagra is used in accordance with the currently approved prescribing information, its safety profile remains favorable. The withdrawal of the application will enable evaluation of further information and additional data that may be required to allow any future assessments under the centralized procedure. Pfizer believes that access to Viagra 50 mg without a prescription in a pharmacy setting in the EU would provide valuable benefits to male patients suffering from ED. Millions of men in Europe are currently circumventing the healthcare system when seeking ED medicines, exposing themselves to unnecessary risks of medicines from uncontrolled sources and the missed opportunity to get important health information from a healthcare professional.